IONETIX Corporation and AlfaRim Medical B.V. announce a strategic partnership to fast-track commercial production of Actinium-225

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

IONETIX-AlfaRim

More Like This

PR Newswire associated0

AtomVie Global Radiopharma and TerraPower Isotopes Announce Strategic Supply Agreement for Actinium-225 to Advance Radiopharmaceutical Development and Manufacturing

PR Newswire associated0

AtomVie Global Radiopharma Supplies the First Patient Dose of 225Ac-SSO110 for Ariceum Therapeutics' Phase 1/2 SANTANA-225 Clinical Trial in Extensive-Stage Small Cell Lung Cancer and Merkel Cell Carcinoma

EQT Life Sciences leads EUR 93 million oversubscribed Series A round in PanTera, which aims to accelerate global actinium - 225 production

PR Newswire associated0

Telix Adds Lead-212 Isotope Production Capability

PR Newswire associated0

Telix Spins Off Rhine Pharma™ to Expand Global Access to Radiopharmaceuticals

Telix Pharmaceuticals Limited completes the acquisition of ARTMS, Inc.

PR Newswire associated0

Telix to Acquire ARTMS, Inc. and its Advanced Isotope Production Platform

PR Newswire associated0

Telix Manufacturing Solutions, Brussels South Update: Cyclotron Installation Complete